Tatva Chintan Pharma Chem Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 966.69 million compared to INR 900.91 million a year ago. Revenue was INR 974.25 million compared to INR 920.37 million a year ago. Net income was INR 77.81 million compared to INR 71.11 million a year ago. Basic earnings per share from continuing operations was INR 3.43 compared to INR 3.21 a year ago. Diluted earnings per share from continuing operations was INR 3.43 compared to INR 3.21 a year ago.
For the six months, sales was INR 2,110.33 million compared to INR 1,784.93 million a year ago. Revenue was INR 2,128.04 million compared to INR 1,823.15 million a year ago. Net income was INR 172.85 million compared to INR 169.09 million a year ago. Basic earnings per share from continuing operations was INR 7.72 compared to INR 7.63 a year ago. Diluted earnings per share from continuing operations was INR 7.72 compared to INR 7.63 a year ago.